As with all medicines, patients and healthcare professionals are advised to use GLP-1 receptor agonists in accordance with the approved product information
Recognizing the need for accessible alternatives, we are proud to introduce sublingual Semaglutide, leveraging an anhydrous MCT base for optimal delivery and absorption
Notably, Elevated levels of 8-OHdG in individuals with IBD have been consistently documented in research, indicating its promising role as a dependable OSM in the context of this disease (123125, 158, 184)
The Philippine FDA approved new formulations, which have shown improved patient adherence rates, with studies indicating a15% increase in compliance
The additional costs to produce semaglutide for the oral formulation are cost-effective over a weekly injection [206]